Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Abiomed is a medical devices business based in the US. Abiomed stocks (ABMD.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $253.79 – an increase of 10.6% over the previous week. Abiomed employs 0 staff and has a trailing 12-month revenue of around $1 billion.
Finder's Pick for
Beginners
Finder's Pick for
Free Trades
Finder's Pick for
Commodity Stocks
Finder's Pick for
US Stocks
| Latest market close | $258.23 |
|---|---|
| 52-week range | $227.25 - $379.30 |
| 50-day moving average | $297.89 |
| 200-day moving average | $323.46 |
| Wall St. target price | $354.17 |
| PE ratio | 85.2886 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $2.98 |
Note: The dollar amounts in the table below are in Canadian dollars.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of $258.23 from 2022-05-17
| 1 week (2022-05-07) | N/A |
|---|---|
| 1 month (2022-04-14) | -15.63% |
| 3 months (2022-02-14) | N/A |
| 6 months (2021-11-18) | -24.09% |
| 1 year (2021-05-18) | -5.40% |
|---|---|
| 2 years (2020-05-18) | 35.16% |
| 3 years (2019-05-17) | 260.48 |
| 5 years (2017-05-17) | 97.82% |
Valuing Abiomed stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Abiomed's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Abiomed's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 85x. In other words, Abiomed shares trade at around 85x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Abiomed's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.75. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Abiomed's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Abiomed's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $284.4 million.
The EBITDA is a measure of a Abiomed's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $1 billion |
|---|---|
| Operating margin TTM | 24.88% |
| Gross profit TTM | $843.6 million |
| Return on assets TTM | 10.13% |
| Return on equity TTM | 9.64% |
| Profit margin | 13.23% |
| Book value | $33.01 |
| Market capitalisation | $11.6 billion |
TTM: trailing 12 months
We're not expecting Abiomed to pay a dividend over the next 12 months.
Abiomed's shares were split on a 2:1 basis on 2 October 2000. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Abiomed shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Abiomed shares which in turn could have impacted Abiomed's share price.
Over the last 12 months, Abiomed's shares have ranged in value from as little as $227.25 up to $379.3. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Abiomed's is 1.325. This would suggest that Abiomed's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2. 5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by interventional cardiologists to support patients in the cath lab, as well as by cardiac surgeons in the heart surgery suite. It also provides Impella 5. 0, Impella LD, and Impella 5.
Enjoy perks like free trades and cash rewards when you open a stock trading account with these online brokers.
Read more…
Here’s what you need to know about investing in the propane industry, including 3 popular propane stocks to watch.
Read more…
Using our proprietary algorithm, we’ve found the best blue chip stocks on the TSX, NYSE and Nasdaq based on price, performance and more.
Read more…Everything we know about the Hanover Bancorp, Inc. IPO, plus information on how to buy in.
Everything we know about the PrimeBlock IPO, plus information on how to buy in.
Everything we know about the Actelis Networks IPO, plus information on how to buy in.
Everything we know about the ProFrac Holding Corp IPO, plus information on how to buy in.
Everything we know about the Wytec International IPO, plus information on how to buy in.
Here are some of the best stocks for inflation periods to reduce the negative impacts of inflation on your portfolio.
Choose from many account and investment types to invest in global markets, but expect to pay high commissions with HSBC InvestDirect, which doesn’t have an app.
Our Flahmingo review tells you how to buy fractional shares of some of your favourite US companies with as little as $1.
Steps to owning and managing EXPD stock, with 24-hour and historical pricing before you buy.
Steps to owning and managing PRU stock, with 24-hour and historical pricing before you buy.
